CIK 0001598646 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in MA · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | 0 | |
| Net income (USD) | -32.1 M | -49.9 M | ||
| Diluted EPS (USD/shares) | -34.67 | -4.61 | -6.01 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-20 | 3 | 3 | 2026-08-10 |
| 2026-08-20 | 3 | 3 | 2026-08-10 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 8-K | 8-K items 5.02 | 2026-08-10 |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-07 | 8-K | 8-K items 2.02,9.01 | 2026-08-07 |
| 2026-08-03 | 4 | 4 | 2026-08-03 |
| 2026-07-08 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-04 | 8-K | 8-K items 3.03,5.03,5.07,9.01 | 2026-06-03 |
| 2026-05-27 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-05-27 |
| 2026-05-27 | 424B5 | 424B5 | |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-05 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-05 | 8-K | 8-K items 2.02,9.01 | 2026-05-05 |
| 2026-04-23 | ARS | ARS | 2025-12-31 |
| 2026-04-23 | DEFA14A | DEFA14A |
Forms on file (last 1,000): 4 228, 8-K 129, 10-Q 37, SC 13G/A 36, 3 31, CORRESP 14, SC 13G 13, DEF 14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=NERV (0.002 USD), /gw/filings/filings?ticker=NERV&form=8-K, /gw/filings/facts?ticker=NERV&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange